HerbaZorb a Patentable Delivery System

MIAMIRZN Nutraceuticals Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for the firms absorption and delivery system process methodology patent application, a technology RZN has named HerbaZorb. Two of the firms most popular product offerings, Arthri-Zen Relief® and Migra-Zen Relief® PLUS capsules already use the technology in their manufacture. The use of this preparation method ensures the rapid and effective absorption of active ingredients.

Among the proprietary characteristics of HerbaZorb noted in the patent application are that it protects beneficial phytochemicals of herbs and herbal extracts from being digested prior to entering the bloodstream, providing a significant advantage to both producers of herbal products and those who consume them. The basis for our patent is that our delivery system represents a breakthrough in the field of bioavailability, the process by which active ingredients are delivered to the bloodstream intact, ensuring their maximum usefulness in the body. said Mark Lubin, founder of RZN Nutraceuticals Inc.

According to company President Robert Hunt, It is very satisfying to us to gain this important recognition for HerbaZorb, especially as we continue making the process available to other manufacturers who want us to prepare their herbal ingredients using this technology.

My goal has always been to develop the most effective and natural pain relief formulations possible, which resulted in the Arthri-Zen Relief® and Migra-Zen Relief® PLUS family of products, Mr. Lubin stated. With the advances in absorption offered by HerbaZorb, we can ensure that everyone in the industry using herbal blends can benefit from maximum bioavailability so the active ingredients in them are utilized most fully by the human body.

RZN Nutraceuticals products are marketed direct to natural accounts, through private label accounts, catalogue sales, practitioner offices, health clubs and are available on companys Web site.